Edwards Lifesciences Corporation Stock News

The market indexes pulled back significantly in the past week, with the NASDAQ 100 ETF losing 11% from its September high to its low this week.

Glenview Capital Management's 13F portfolio value decreased from $3.68B to $3.63B this quarter. The number of positions decreased from 44 to 43.

The S&P 500's sell-off accelerates. The best sectors and stocks to consider when it bottoms.

Baxter continues to chug on slowly as it has done for the past 10 years, delivering ongoing value to shareholders.

We're seeing shifts in sector leadership that are worth watching. Our overbought indicator suggests reigning in risk.

These stocks had the most buys from gurus Continue reading...

Guru adds to Edwards Lifesciences, trims Nvidia and Apple Continue reading...

Our overbought indicator reaches rarefied air. It could be a good time to rein in risk by reducing margin and avoiding short-term calls.

Sands Capital Management invests in communications and health care in 2nd quarter Continue reading...

Edwards Lifesciences Corporation's (NYSE:EW) price-to-earnings (or "P/E") ratio of 64.3x might make it look like a...

Mike Mussallem became the CEO of Edwards Lifesciences Corporation (NYSE:EW) in 2000, and we think it's a good time to...

Edwards Lifesciences Corp (NYSE:EW) VP Donald E. Bobo, Jr. sold 12,000 shares of the company’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $77.28, for

Orbimed Advisors reduced stake in Inspire Medical Systems Inc.

The next generation of videogame consoles could spur gamers to upgrade their systems, creating demand for graphics-processing cards, according to BofA Securities analyst Vivek Arya.